fda warning letters compounded semaglutide 2025 september warns consumers not to use counterfeit Ozempic (semaglutide) found in the U.S. drug supply chain. The agency recently seized dozens of units of counterfeit Ozempic (semaglutide) injection 1 mg that were The FDA has warned six

Mar 24, 2026 What if the burning sensation you noticed last week has nothing to do with semaglutide itself, and everything to do with how your body is responding to treatment

Earlier evaluation is warranted with known risk factors such as irregular menses, amenorrhea lasting more than 3 months, severe male factor, endometriosis, or pelvic disease

9 Distinguishing failed biology from failed pharmacology: a decision framework A central objective of this review is to distinguish peptidereceptor systems that were abandoned due to intrinsic biological limitations from those that failed primarily because of incomplete pharmacologic execution

They often reflect biological systems that regulate hunger, fullness, glucose handling, and energy balance